RPS9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.629960E-01
Normal-vs-Stage2
5.319200E-01
Normal-vs-Stage3
4.609000E-01
Normal-vs-Stage4
8.464600E-01
Stage1-vs-Stage2
4.422000E-01
Stage1-vs-Stage3
9.628000E-01
Stage1-vs-Stage4
2.723000E-01
Stage2-vs-Stage3
4.978600E-01
Stage2-vs-Stage4
6.430000E-01
Stage3-vs-Stage4
5.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.260000E-01
Normal-vs-AfricanAmerican
5.681800E-01
Normal-vs-Asian
9.462200E-01
Caucasian-vs-AfricanAmerican
7.412800E-01
Caucasian-vs-Asian
5.536200E-01
AfricanAmerican-vs-Asian
6.592000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.872800E-01
Normal-vs-Female
3.226600E-01
Male-vs-Female
2.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.133800E-01
Normal-vs-Age(41-60Yrs)
1.707230E-01
Normal-vs-Age(61-80Yrs)
6.912600E-01
Normal-vs-Age(81-100Yrs)
8.628000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.917600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.650000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.078600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.032300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.421700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.730000E-01
Normal-vs-Daily Drinker
9.354400E-01
Normal-vs-Weekly Drinker
9.308000E-01
Normal-vs-Occasional Drinker
9.660200E-01
Normal-vs-Social Drinker
1.421850E-02
Non Drinker-vs-Daily Drinker
1.301400E-01
Non Drinker-vs-Weekly Drinker
6.004600E-01
Non Drinker-vs-Occasional Drinker
5.535900E-02
Non Drinker-vs-Social Drinker
4.167600E-02
Daily Drinker-vs-Weekly Drinker
9.167400E-01
Daily Drinker-vs-Occasional Drinker
8.091400E-01
Daily Drinker-vs-Social Drinker
2.778300E-03
Weekly Drinker-vs-Occasional Drinker
8.280800E-01
Weekly Drinker-vs-Social Drinker
2.463800E-01
Occasional Drinker-vs-Social Drinker
3.623000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.273200E-01
Normal-vs-Grade 2
9.372800E-01
Normal-vs-Grade 3
9.463600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.112400E-01
Grade 1-vs-Grade 3
3.305000E-01
Grade 1-vs-Grade 4
8.273200E-01
Grade 2-vs-Grade 3
9.895600E-01
Grade 2-vs-Grade 4
9.372800E-01
Grade 3-vs-Grade 4
9.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.726400E-01
Normal-vs-NonDiabetic
5.804200E-01
Diabetic-vs-NonDiabetic
5.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.115800E-01
Normal-vs-NoPancreatitis
6.295000E-01
Pancreatitis-vs-NoPancreatitis
5.598800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.981200E-01
Normal-vs-N1
5.377600E-01
N0-vs-N1
5.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.247200E-01
Normal-vs-TP53-NonMutant
5.107800E-01
TP53-Mutant-vs-TP53-NonMutant
5.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
